2,3-DHB ineffective in treatment of iron overload.
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D062385:Hydroxybenzoates / Q000627:therapeutic use*; D013789:Thalassemia / Q000188:drug therapy*
D062385:Hydroxybenzoates